As of tomorrow, individual genetic risk tests are officially exempt from requiring 510(k) premarket approval, provided the company offering the test has gone through a one-time premarket review of its testing apparatus and at least one test.
The notice, which will be officially published tomorrow in the Federal Registry, finalizes a guidance that was originally proposed in November 2017.
"Today,...
